三、小结
到目前为止,针对散发性AD的治疗仍然缺乏有效手段。近年来,随着分子生物学、神经生物学及神经影像学等多学科知识和研究手段的快速发展,通过基因表达和全基因组关联研究确定的其他分子机制或危险基因都可以作为特异性药理学靶点。选择健康生活方式、开发多靶点药物来预防或治疗AD逐渐受到大家重视。
参考文献
[1]Querfurth HW,LaFerla FM.Alzheimer's disease[J].N Engl J Med,2010,362(4):329-344.
[2]cden Dunnen WF,Brouwer WH,Bijlard E,et al.No disease in the brain of a 115-year-old woman[J].Neurobiol Aging,2008,29(8):1127-1132.
[3]Savva GM,Wharton SB,Ince PG,et al.Age,neuropathology,and dementia[J].N Engl J Med,2009,360(22):2302-2309.
[4]Swerdlow RH,Burns JM,Khan SM.The Alzheimer's disease mitochondrial cascade hypothesis:Progress and perspectives[J].Biochim Biophys Acta,2014,1842(8):1219-1231.
[5]Chen JX,Yan SS.Role of mitochondrial amyloid-beta in Alzheimer's disease[J].J Alzheimer Dis,2010,20(Suppl 2):S569-S578.
[6]Burté F,Carelli V,Chinnery PF,et al.Disturbed mitochondrial dynamics and neurodegenerative disorders[J].Nat Rev Neurol,2015,11(1):11-24.
[7]Nunomura A,Perry G,Aliev G,et al.Oxidative damage is the earliest event in Alzheimer disease[J].J Neuropathol Exp Neurol,2001,60(8):759-767.
[8]Wang X,Wang W,Li L,et al.Oxidative stress and mitochondrial dysfunction in Alzheimer's disease[J].Biochim Biophys Acta,2014,1842(8):1240-1247.
[9]Xu PX,Wang SW,Yu XL,et al.Rutin improves spatial memory in Alzheimer's disease transgenic mice by reducing Aβ oligomer level and attenuating oxidative stress and neuroinflammation[J].Behav Brain Res,2014,264:173-180.
[10]Steen E,Terry BM,Rivera EJ,et al.Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes?[J].J Alzheimers Dis,2005,7(1):63-80.
[11]Candeias E,Duarte AI,Carvalho C,et al.The impairment of insulin signaling in Alzheimer's disease[J].IUBMB Life,2012,64(12):951-957.
[12]Pimentel-Coelho PM,Rivest S.The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease[J].Eur J Neurosci,2012,35(12):1917-1937.
[13]Casserly I,Topol E.Convergence of atherosclerosis and Alzheimer's disease:inflammation,cholesterol,and misfolded proteins[J].Lancet,2004,363(9415):1139-1146.
[14]Deane R,Zlokovic BV.Role of the blood-brain barrier in the pathogenesisof Alzheimer's disease[J].Curr Alzheimer Res,2007,4(2):191-197.(https://www.daowen.com)
[15]Hoffman LB,Schmeidler J,Lesser GT,et al.Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons[J].Neurology,2009,72(20):1720-1726.
[16]Wyss-Coray T,Mucke L.Inflammation in neurodegenerative disease-a double-edged sword[J].Neuron,2002,35(3):419-432.
[17]Block ML,Zecca L,Hong JS.Microglia - mediated neurotoxicity:uncovering the molecular mechanisms[J].Nat Rev Neurosci,2007,8(1):57-69.
[18]Cameron B,Landreth GE.Inflammation,microglia,and Alzheimer's disease[J].Neurobiol Dis,2010,37(3):503-509.
[19]Yamazaki D,Horiuchi J,Ueno K,et al.Glial dysfunction causes agerelated memory impairment in Drosophila[J].Neuron,2014,84(4):753-763.
[20]Lim D,Ronco V,Grolla AA,et al.Glial calcium signalling in Alzheimer's disease[J].Rev Physiol Biochem Pharmacol,2014,167:45-65.
[21]Peng D,Yuan X,Zhu R.Memantine hydrochloride in the treatment of dementia subtypes[J].J Clin Neurosci,2013,20(11):1482-1485.
[22]Saravanaraman P,Chinnadurai RK,Boopathy R.Why calcium channel blockers could be an elite choice in the treatment of Alzheimer's disease:a comprehensive review of evidences[J].Rev Neurosci,2014,25(2):231-246.
[23]Wirths O,Weis J,Szczygielski J,et al.Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer's disease[J].Acta Neuropathol,2006,111(4):312-319.
[24]Christensen DZ, Huettenrauch M, Mitkovski M, et al.Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation[J].Front Aging Neurosci,2014,6:139.
[25]Ballatore C,Brunden KR,Huryn DM,et al.Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies[J].J Med Chem,2012,55(21):8979-8996.
[26]Busser J,Geldmacher DS,Herrup K.Ectopic cell cycle proteins predictthe sites of neuronal cell death in Alzheimer's disease brain[J].J Neurosci,1998,18(8):2801-2807.
[27]Wood WG,Li L,Müller WE.Eckert GP.Cholesterol as a causative factor in Alzheimer's disease:a debatable hypothesis[J].J Neurochem,2014,129(4):559-572.
[28]Liu JP,Tang Y,Zhou S,et al.Cholesterol involvement in the pathogenesis of neurodegenerative diseases[J].Mol Cell Neurosci,2010,43(1):33-42.
[29]Hutter-Paier B,Huttunen HJ,Puglielli L,et al.The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease[J].Neuron,2004,44(2):227-238.
(钱 云)